← All candidates
32 insider filings on record.
32 filings on record.
IMCRImmunocore Holdings plc
NasdaqGS · Healthcare · $1.57B
$30.88
-2.11% · Sep 15
32 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 12 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$1.57B
Float
42.5M
83% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
3.8
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
27 more transactions on Pro →Context
Wall St
$62.50 avg target
+102.4% vs today · 12 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 4 quarters beat
Q2 '26−$0.02 act−$0.04
Q1 '26$0.25 act+$0.51
Q4 '25−$0.60 act−$0.40
Q3 '25$0.00 act+$0.24
Coverage
Immunocore's Q2 Earnings Miss Estimates, Kimmtrak Aids Y/Y RevenuesZacks · 08-07Wall Street Analysts See a 77.91% Upside in Immunocore (IMCR): Can the Stock Really Move This High?Zacks · 08-07How Strong H1 Profits and Kimtrak Survival Data At Immunocore (IMCR) Have Changed Its Investment StorySimply Wall St. · 08-07Immunocore Q2 Earnings Call HighlightsMarketBeat · 08-06
The file stays open
32 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice